Efficacy of Subthreshold Micropulse Laser for Central Serous Chorioretinopathy
Klinische Monatsblätter für Augenheilkunde · 01.04.2024 · 241 (04) · 489-495
DOI: 10.1055/a-2229-2298 ↗Kurz gefasst
Fachartikel in der Zeitschrift Klinische Monatsblätter für Augenheilkunde, erschienen am 01.04.2024. Verfasst von Katrin Fasler und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, University Hospital Zurich, University of Zurich, Frauenklinikstrasse 24, 8091 Zurich, Switzerland. Hauptthemen laut MEDLINE: Central Serous Chorioretinopathy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben.
Abstract (Originalsprache)
Purpose
To evaluate the efficacy of a subthreshold micropulse laser (SML) in patients with central serous chorioretinopathy (CSCR).
Methods
Retrospective clinical study conducted at the Departments of Ophthalmology at a university and a municipal hospital in Zurich, Switzerland. We enrolled acute and chronic CSCR patients with persistent subretinal fluid (SRF) treated with SML. Two treatment protocols (fluorescein/indocyanine green angiography or optical coherence tomography guided) were evaluated for efficacy after 3 and 6 months. The primary outcomes of the study were reduction and percentage of eyes with complete resolution of SRF 3 and 6 months after SML treatment. Secondary endpoints included changes in central subfield thickness (CST) and visual acuity (VA) after 3 and 6 months.
Results
The study involved 37 eyes (35 patients, 48.6% chronic). A statistically significant reduction in SRF height and CST could be shown, irrespective of SRF duration, type of CSCR, or chosen guidance after 3 and 6 months: SRF − 40 µm (p < 0.01), CST − 52 µm (p < 0.01). Percentage of eyes with complete resolution of fluid at 3 and 6 months after SML were 24.3 and 21.6%, respectively. No statistically significant functional improvement (VA) could be shown. Multivariable regression and linear mixed regression analyses did not identify statistically significant differences in SRF reduction, CMT change, or VA improvement with respect to the type of CSCR or the treatment plan used (p > 0.05).
Conclusion
The effectiveness of SML in CSCR is under continuous debate. Our study findings demonstrate structural but only little functional changes with SML. In view of the shortage of verteporfin for photodynamic therapy, SML remains an important therapeutic option for CSCR patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Ophthalmology, University Hospital Zurich, University of Zurich, Frauenklinikstrasse 24, 8091 Zurich, Switzerland.
- Ophthalmology, Stadtspital Zürich Triemli, Zürich, Switzerland.
- Ophthalmology, Gutblick Research, Pfäffikon, Switzerland.
- Spross Research Institute, Zürich, Switzerland.
- Department of Ophthalmology, Semmelweis University, Budapest, Hungary.
- Hunter New England Health, New South Wales, Australia.
ORCID-Profile: Sandrine Zweifel, Gabor Mark Somfai
Zitieren
APA
Fasler, K., Turgut, F., Gunzinger, J. M., Sommer, C., Muth, D. R., Kinzl, S., Nilius, H., Zweifel, S., & Somfai, G. M. (2024). Efficacy of Subthreshold Micropulse Laser for Central Serous Chorioretinopathy. Klinische Monatsblätter für Augenheilkunde, 241(04), 489-495. https://doi.org/10.1055/a-2229-2298
Vancouver
Fasler K, Turgut F, Gunzinger JM, Sommer C, Muth DR, Kinzl S, et al. Efficacy of Subthreshold Micropulse Laser for Central Serous Chorioretinopathy. Klinische Monatsblätter für Augenheilkunde. 2024;241(04):489-495. doi:10.1055/a-2229-2298
BibTeX
@article{Fasler2024,
author = {Fasler, Katrin and Turgut, Ferhat and Gunzinger, Jeanne Martine and Sommer, Chiara and Muth, Daniel Rudolf and Kinzl, Stephan and Nilius, Henning and Zweifel, Sandrine and Somfai, Gabor Mark},
title = {Efficacy of Subthreshold Micropulse Laser for Central Serous Chorioretinopathy},
journal = {Klinische Monatsblätter für Augenheilkunde},
year = {2024},
volume = {241},
number = {04},
pages = {489--495},
doi = {10.1055/a-2229-2298}
}
EUVIMED